Compumedics Limited (ASX:CMP)

Market Cap	55.93M -16.8%
Revenue (ttm)	58.49M +23.5%
Net Income	113.00K
EPS	0.00
Shares Out	199.76M
PE Ratio	494.98
Forward PE	18.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,301
Average Volume	45,962
Open	0.2750
Previous Close	0.2800
Day's Range	0.2750 - 0.2800
52-Week Range	0.2400 - 0.4500
Beta	0.34
RSI	44.44
Earnings Date	May 22, 2026

About Compumedics

Compumedics Limited researches, develops, manufactures, sells, and distributes medical devices in Australia, the Asia Pacific, the Americas, Europe, and the Middle East. It provides sleep diagnostics products, including Grael 4K PSG:EEG amplifiers; Somté PSG; Siesta 802, an ambulatory recording device; Okti; Grael PSG; Grael DC; Somfit/Somfit Pro, a wearable device; TCM5 FLEX Transcutaneous monitor; and Somté, an investigative tool. The company also provides neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 175
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CMP

Financial Performance

In fiscal year 2025, Compumedics's revenue was 51.04 million, an increase of 1.55% compared to the previous year's 50.26 million. Losses were -1.27 million, 275.1% more than in 2024.